The metabolic syndrome, diabetes and lung dysfunction

Area of Science:

• Pulmonary Medicine
• Endocrinology
• Cardiovascular Medicine

Background:

• Sleep-disordered breathing and sleep apnea frequently coexist with obesity, diabetes, hypertension, metabolic syndrome, and cardiovascular disease.
• Diabetic states (Type 1 and Type 2) can impair lung function, notably decreasing vital capacity.
• A shared inflammatory process may link chronic obstructive pulmonary disease (COPD) and Type 2 diabetes.

Purpose of the Study:

• To explore the interconnectedness of sleep-disordered breathing, metabolic disorders, and cardiovascular disease.
• To highlight common pathophysiological mechanisms underlying these comorbidities.

Main Methods:

• Review of existing literature on sleep-disordered breathing, diabetes, COPD, metabolic syndrome, and cardiovascular disease.
• Analysis of shared etiological factors and pathophysiological pathways.

Main Results:

• Sleep-disordered breathing and sleep apnea are associated with a spectrum of metabolic and cardiovascular comorbidities.
• Diminished lung function, including reduced vital capacity, is observed in diabetic patients.
• Endothelial dysfunction is a common underlying factor in respiratory diseases, metabolic syndrome, and cardiovascular disease, indicated by alterations in circulating endothelial progenitor cells.

Conclusions:

• Sleep-disordered breathing, metabolic disorders, and cardiovascular diseases share common inflammatory and endothelial dysfunction pathways.
• Understanding these shared mechanisms is crucial for comprehensive patient management and treatment strategies.